Anavex Life Sciences
AVXL
61 hedge funds and large institutions have $42.6M invested in Anavex Life Sciences in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 7 closing their positions.
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
7% more capital invested
Capital invested by funds: $39.7M → $42.6M (+$2.96M)
3% more funds holding
Funds holding: 59 → 61 (+2)
2.18% more ownership
Funds ownership: 23.35% → 25.52% (+2.2%)
83% less call options, than puts
Call options by funds: $384K | Put options by funds: $2.32M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.3M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.06M |
| 3 |
HP
Hikari Power
Tokyo,
Japan
|
+$848K |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$721K |
| 5 |
State Street
Boston,
Massachusetts
|
+$432K |
Top Sellers
| 1 |
Jane Street
New York
|
-$480K |
| 2 |
Millennium Management
New York
|
-$247K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$235K |
| 4 |
D.E. Shaw & Co
New York
|
-$120K |
| 5 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$81K |
AVXL Hedge Fund Activity: Q3 2019 in Review
61 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2019, worth a combined $42.6M — up 7.5% from $39.7M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AVXL positions and 7 closed out — a net gain of 2 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.3M. The largest seller was Jane Street, exiting entirely with an estimated $480K sold.
- 61 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2019, up from 59 in Q2 2019.
- Funds reported $42.6M of Anavex Life Sciences stock for Q3 2019, up 7.5% quarter-over-quarter.
- 9 funds opened new Anavex Life Sciences positions in Q3 2019 and 7 closed out, a net change of +2 holders.
- The largest Anavex Life Sciences buyer in Q3 2019 was Vanguard Group, an estimated $1.3M added.
- The largest Anavex Life Sciences seller in Q3 2019 was Jane Street, an estimated $480K sold.
Based on aggregated 13F filings for Q3 2019.